How to identify better candidate to radioembolization in case of hepatocellular carcinoma and portal vein tumoral thrombosis.
作者信息
Levi Sandri Giovanni Battista, Rayar Michel
机构信息
Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Service de Chirurgie Hépatobiliaire et Digestive, CHU Rennes, Rennes, France.
出版信息
Hepatobiliary Surg Nutr. 2019 Feb;8(1):63-64. doi: 10.21037/hbsn.2018.11.03.
Abstract
摘要
相似文献
1
How to identify better candidate to radioembolization in case of hepatocellular carcinoma and portal vein tumoral thrombosis.在肝细胞癌合并门静脉肿瘤性血栓形成的情况下，如何识别更适合进行放射性栓塞治疗的候选者。
Hepatobiliary Surg Nutr. 2019 Feb;8(1):63-64. doi: 10.21037/hbsn.2018.11.03.
2
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.开发一种预后评分，以预测伴有门静脉侵犯的肝细胞癌对钇-90 放射性栓塞治疗的反应。
J Hepatol. 2018 Apr;68(4):724-732. doi: 10.1016/j.jhep.2017.12.026. Epub 2018 Jan 10.
3
Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.肝细胞癌伴或不伴门静脉血栓形成患者接受放射性栓塞后的良好生存时间。
Cancer Biother Radiopharm. 2015 Apr;30(3):132-8. doi: 10.1089/cbr.2014.1748. Epub 2015 Mar 11.
4
Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.钇 90 放射性栓塞治疗合并门静脉血栓形成的局部进展期肝细胞癌：185 例患者队列的长期结果。
J Nucl Med. 2018 Jul;59(7):1042-1048. doi: 10.2967/jnumed.117.199752. Epub 2017 Dec 7.
5
Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.比较放射性栓塞与索拉非尼治疗伴有门静脉癌栓的肝细胞癌：安全性和疗效的系统评价和荟萃分析。
Korean J Radiol. 2019 Mar;20(3):385-398. doi: 10.3348/kjr.2018.0496.
6
Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma.门静脉栓塞后行放射性栓塞术治疗多灶性肝细胞癌。
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1519-23. doi: 10.1007/s00270-012-0376-2. Epub 2012 Apr 14.
7
Hepatic arterial blood flow in large hepatocellular carcinoma with or without portal vein thrombosis: assessment by transcutaneous duplex Doppler sonography.伴有或不伴有门静脉血栓形成的大肝细胞癌的肝动脉血流：经皮双功多普勒超声评估
Eur J Gastroenterol Hepatol. 2002 Feb;14(2):167-76. doi: 10.1097/00042737-200202000-00011.
8
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.根据肿瘤形态和门静脉血栓形成情况评估放射性栓塞术治疗中晚期肝细胞癌的疗效
Future Oncol. 2015;11(23):3133-42. doi: 10.2217/fon.15.267. Epub 2015 Oct 15.
9
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.放射性栓塞是治疗伴有门静脉血栓形成的肝细胞癌的一种安全有效的方法：一项倾向评分分析。
PLoS One. 2016 May 5;11(5):e0154986. doi: 10.1371/journal.pone.0154986. eCollection 2016.
10
Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion".回复：“钇-90放射性栓塞治疗门静脉侵犯的肝细胞癌疗效验证”
J Hepatol. 2018 Jul;69(1):260-261. doi: 10.1016/j.jhep.2018.04.008. Epub 2018 Apr 27.
本文引用的文献
1
Resection for hepatocellular cancer: overpassing old barriers.肝细胞癌切除术：跨越旧有障碍。
Transl Gastroenterol Hepatol. 2018 Sep 17;3:64. doi: 10.21037/tgh.2018.09.13. eCollection 2018.
2
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.腹腔镜肝切除术治疗位于不利部位的肝细胞癌：来自意大利微创肝外科组（I Go MILS）登记处的倾向评分匹配分析。
Surg Endosc. 2019 May;33(5):1451-1458. doi: 10.1007/s00464-018-6426-3. Epub 2018 Sep 10.
3
Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size.腹腔镜肝切除术治疗大 HCC：肿瘤大小与短期和长期预后的关系。
Surg Endosc. 2018 Dec;32(12):4772-4779. doi: 10.1007/s00464-018-6225-x. Epub 2018 May 16.
4
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.开发一种预后评分，以预测伴有门静脉侵犯的肝细胞癌对钇-90 放射性栓塞治疗的反应。
J Hepatol. 2018 Apr;68(4):724-732. doi: 10.1016/j.jhep.2017.12.026. Epub 2018 Jan 10.
5
Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.经动脉放射性栓塞术：肝细胞癌患者获得肝移植的新契机，一项全球综述
Transl Gastroenterol Hepatol. 2017 Nov 27;2:98. doi: 10.21037/tgh.2017.11.11. eCollection 2017.
6
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.移植前接受钇-90放射性栓塞治疗的伴大血管侵犯的肝细胞癌
Hepatobiliary Surg Nutr. 2017 Feb;6(1):44-48. doi: 10.21037/hbsn.2017.01.08.
7
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.与肝动脉化疗栓塞术相比，钇-90放射性栓塞术显著延长了肝细胞癌患者的疾病进展时间。
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
8
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.肝移植前钇-90放射性栓塞治疗肝细胞癌
World J Surg. 2017 Jan;41(1):241-249. doi: 10.1007/s00268-016-3682-z.
9
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion.肝切除术治疗伴有门静脉侵犯的肝细胞癌的生存获益。
J Hepatol. 2016 Nov;65(5):938-943. doi: 10.1016/j.jhep.2016.05.044. Epub 2016 Jun 4.
10
Bridging and downstaging to transplantation in hepatocellular carcinoma.肝细胞癌的桥接治疗及降期至可移植状态
Future Oncol. 2014 Nov;10(15 Suppl):61-3. doi: 10.2217/fon.14.226.
Zotero 插件